BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12458915)

  • 1. Development immunotoxicology and risk assessment. Conclusions and future directions: a personal view from the session chair.
    Dayan AD
    Hum Exp Toxicol; 2002; 21(9-10):569-72. PubMed ID: 12458915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental immunotoxicology and risk assessment: a workshop summary.
    Holsapple MP
    Hum Exp Toxicol; 2002; 21(9-10):473-8. PubMed ID: 12458903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of a workshop on nonclinical and clinical immunotoxicity assessment of immunomodulatory drugs.
    Piccotti JR; Lebrec HN; Evans E; Herzyk DJ; Hastings KL; Burns-Naas LA; Gourley IS; Wierda D; Kawabata TT
    J Immunotoxicol; 2009 Mar; 6(1):1-10. PubMed ID: 19519157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.
    Boverhof DR; Ladics G; Luebke B; Botham J; Corsini E; Evans E; Germolec D; Holsapple M; Loveless SE; Lu H; van der Laan JW; White KL; Yang Y
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):96-107. PubMed ID: 24280359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of the rat in developmental immunotoxicology studies.
    Chapin RE
    Hum Exp Toxicol; 2002; 21(9-10):521-3. PubMed ID: 12458910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotoxicity Testing and Risk Assessment: summary of a 1994 workshop. Immunotoxicology Technical Committee ILSI Health and Environmental Sciences Institute.
    Food Chem Toxicol; 1995 Oct; 33(10):887-94. PubMed ID: 7590534
    [No Abstract]   [Full Text] [Related]  

  • 7. The mouse as a model for developmental immunotoxicology.
    Holladay SD; Blaylock BL
    Hum Exp Toxicol; 2002; 21(9-10):525-31. PubMed ID: 12458911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current developments in reproductive toxicity testing of pesticides.
    Cooper RL
    Reprod Toxicol; 2009 Sep; 28(2):180-7. PubMed ID: 19409482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent transitions in mechanisms of toxicity.
    Slikker W; Andersen ME; Bogdanffy MS; Bus JS; Cohen SD; Conolly RB; David RM; Doerrer NG; Dorman DC; Gaylor DW; Hattis D; Rogers JM; Setzer RW; Swenberg JA; Wallace K
    Toxicol Appl Pharmacol; 2004 Dec; 201(3):203-25. PubMed ID: 15582645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental immunotoxicity testing: a review.
    Holsapple MP
    Toxicology; 2003 Apr; 185(3):193-203. PubMed ID: 12581694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview: developmental toxicology: new directions.
    Shuey D; Kim JH
    Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):381-3. PubMed ID: 21770024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental Immunotoxicology and Risk Assessment. Proceedings of a workshop. 12-13 June 2001, Washington, DC, USA.
    Hum Exp Toxicol; 2002; 21(9-10):469-572. PubMed ID: 12458902
    [No Abstract]   [Full Text] [Related]  

  • 14. Issues with introducing new immunotoxicology methods into the safety assessment of pharmaceuticals.
    Dean JH
    Toxicology; 1997 Apr; 119(1):95-101. PubMed ID: 9129200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicology in the 21st century--working our way towards a visionary reality.
    Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
    Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental toxicology: new directions workshop: refining testing strategies and study designs.
    Brannen KC; Fenton SE; Hansen DK; Harrouk W; Kim JH; Shuey D
    Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):404-12. PubMed ID: 22006510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus workshop on methods to evaluate developmental immunotoxicity.
    Luster MI; Dean JH; Germolec DR
    Environ Health Perspect; 2003 Apr; 111(4):579-83. PubMed ID: 12676619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigative Immunotoxicology.
    Anderson SE; Shane HL
    Methods Mol Biol; 2018; 1803():27-46. PubMed ID: 29882131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental immunotoxicology: emerging issues.
    Dietert RR; Lee JE; Bunn TL
    Hum Exp Toxicol; 2002; 21(9-10):479-85. PubMed ID: 12458904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.